Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
43.72
-0.06 (-0.14%)
At close: Aug 14, 2026, 4:00 PM EDT
43.83
+0.11 (0.25%)
After-hours: Aug 14, 2026, 7:30 PM EDT

Sanofi Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
48,91946,71644,28641,10940,30439,175
Revenue Growth
6.96%5.49%7.73%2.00%2.88%4.83%
Gross Profit
35,93233,79331,09128,49028,43526,924
Operating Income
10,3509,6508,8698,12110,3818,565
Net Income
3,9587,8135,5605,4008,3716,223
Earnings Per Share
3.266.374.444.316.674.95
EPS Growth
-55.56%43.55%2.94%-35.31%34.73%-49.28%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dupixent
17,72615,71413,07210,7158,2935,249
Pharma
38,00535,69032,783---
Total Vaccine
7,8387,9368,2987,4747,2296,323
Revenue (Total)
48,91946,71644,28641,61840,56139,175

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6,3507,6747,5568,82212,88210,109
Total Debt
23,57620,32917,91318,42321,21222,415
Net Cash (Debt)
-17,226-12,655-10,357-9,601-8,330-12,306
Net Cash Growth
------
Net Cash Per Share
-14.20-10.33-8.25-7.64-6.63-9.78

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
11,83810,7509,08110,25810,52610,522
Capital Expenditures
-1,799-1,762-1,733-1,619-1,529-1,478
Free Cash Flow
10,0398,9887,3488,6398,9979,044
Free Cash Flow Growth
5.47%22.32%-14.94%-3.98%-0.52%46.72%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
73.45%72.34%70.20%69.30%70.55%68.73%
Operating Margin
21.16%20.66%20.03%19.75%25.76%21.86%
Pretax Margin
10.62%12.89%15.26%14.88%24.79%20.01%
Profit Margin
8.09%16.72%12.55%13.14%20.77%15.88%
FCF Margin
20.52%19.24%16.59%21.02%22.32%23.09%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.7654.1203.9203.7603.5603.330
Dividend Per Share Growth
10.40%5.10%4.25%5.62%6.91%4.06%
Dividend Yield
4.04%10.38%9.03%9.24%8.92%8.82%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
23.1712.8821.0420.8413.4617.87
P/FCF Ratio
9.0211.2015.9213.0312.5212.30
PS Ratio
1.872.152.642.742.802.84